Nextage Therapeutics Ltd (TLV:NXTG)
Israel · Delayed Price · Currency is ILS · Price in ILA 59.00
+8.10 (15.91%)
At close: Jun 12, 2026
Nextage Therapeutics Market Cap
Nextage Therapeutics has a market cap or net worth of 19.88 million as of June 12, 2026. Its market cap has decreased by -1.38% in one year.
Market Cap
19.88M
Enterprise Value
32.00M
Revenue
243.00K
Ranking
n/a
PE Ratio
3.67
Stock Price
59.00
Market Cap Chart
Since February 29, 2024, Nextage Therapeutics's market cap has increased from 12.50M to 19.88M, an increase of 59.04%. That is a compound annual growth rate of 22.51%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 12, 2026 | 19.88M | -16.33% |
| Dec 31, 2024 | 23.76M | 90.07% |
| Feb 29, 2024 | 12.50M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Teva Pharmaceutical Industries | 116.02B |
| Kamada | 1.24B |
| InterCure | 140.86M |
| Rekah Pharmaceutical Industry | 119.85M |
| Seach Medical Group | 77.13M |
| Together Pharma | 41.58M |
| Tikun Olam-Cannbit Pharmaceuticals | 12.65M |
| PsyRX CNS Bio-Tech | 10.65M |